Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,729
Total Claims
$1.2M
Drug Cost
685
Beneficiaries
$1,699
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-70%
Opioid rate vs peers
0.7% vs 2.2% avg
+20%
Cost per patient vs peers
$1,699 vs $1,411 avg
+2%
Brand preference vs peers
10.9% vs 10.6% avg
Opioid Prescribing
0.7%
Opioid Rate
71
Opioid Claims
$7,615
Opioid Cost
22.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,157 claims · $878K
Generic: 9,503 claims · $282K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 98 | $156K |
| Apixaban | 67 | $80K |
| Fluticasone/Umeclidin/Vilanter | 53 | $74K |
| Rivaroxaban | 30 | $47K |
| Sitagliptin Phosphate | 23 | $34K |
| Linaclotide | 41 | $29K |
| Dapagliflozin Propanediol | 18 | $28K |
| Semaglutide | 17 | $27K |
| Dulaglutide | 22 | $26K |
| Vibegron | 24 | $25K |
| Budesonide/Formoterol Fumarate | 18 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $19K |
| Icosapent Ethyl | 27 | $19K |
| Semaglutide | 14 | $18K |
| Bempedoic Acid | 13 | $16K |
Prescribing Profile
Patient Profile
72
Avg Age
53%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About